Trials / Completed
CompletedNCT00202553
S90652 in Paediatric Hypertension
Acceptability, Safety, Pharmacokinetics and Effects on Blood Pressure of a Daily Dose of 0.025 to 0.135 Milligram Per Kilogram of S90652, a Paediatric Formulation of Perindopril, in 2-16 Years Old Hypertensive Children - 3 Month Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Institut de Recherches Internationales Servier · Academic / Other
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the acceptability, safety and pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril given in hypertensive children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perindopril |
Timeline
- Start date
- 2003-07-01
- Completion
- 2006-12-01
- First posted
- 2005-09-20
- Last updated
- 2018-04-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00202553. Inclusion in this directory is not an endorsement.